Other News Releases in OTC, SmallCap
Genesis Fluid Solutions Holdings, Inc. Announces Completion of Merger Transaction, $3.5 Million Equity Financing and Begins Trading Under Symbol 'GSFL'
Electronic Game Card, Inc. Files 10-Q for Period Ending September 30, 2009
Destiny Media Technologies to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
See more news releases in: OTC, SmallCap, Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals
Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
OMAHA, Neb., Nov. 5 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) announces the following Webcast:
What: Transgenomic, Inc. Third Quarter 2009 Earnings Release
Conference Call
When: Thursday, November 5, 2009 @ 5:00 p.m. Eastern
Where: http://www.transgenomic.com/events.asp?id=6
How: Live over the Internet -- Simply log on to the web at the
address above.
Contact: Investor Relations, 402-452-5400
To access the call via telephone, call 800-862-9098 or 785-424-1051. A replay of the call will be available via telephone until 11:59 pm ET on Thursday, November 19, 2009. To access, dial 800-839-3613 or 402-220-2973.
About Transgenomic, Inc.
Transgenomic, Inc. (OTC BB: TBIO.OB, www.transgenomic.com ) is a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis, providing products and services in DNA mutation detection and discovery for clinical research, clinical molecular diagnostics and pharmacogenomics analyses. Its product offerings include the WAVE® Systems and associated consumables specifically designed for use in genetic variation detection and single- and double-strand DNA/RNA analysis and purification. With broad applicability to genetic research, over 1,450 systems have been shipped to customers in more than 30 countries. The SURVEYOR®( )Mutation Detection Kits and SURVEYOR Check-It Kit provide reagents and protocols for high sensitivity detection of mutations in DNA. In addition, HANABI automated chromosome harvesting systems improve laboratory productivity with consistent quality compared to manual methods for cytogenetic analyses. Service offerings include the Transgenomic Molecular Laboratory, which provides reference laboratory services specializing in molecular diagnostics including Mitochondrial Disorders, Oncology and Hematology, Molecular Pathology and Inherited Diseases. Transgenomic Pharmacogenomic Services is a CRO for pharmacogenomic, translational research and clinical trials.
SOURCE Transgenomic, Inc.